1Hussain Z, Quigley EM. Systematic review: Complementary and alternative medicine in the irritable bowel syndrome[J]. Aliment Pharmacol Ther,2006,23(4) :465 - 471.
2Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors[J ]. Gastroenterol Clin North Am ,2005,34(2) : 189- 204.
3Drossman DA. Diagnosis and treating with refractory functional gastrointestinal disorders. Ann Intern Med, 1995,123:688.
4Drossman DA. The functional disorders and the Rome Ⅱ process;Gut, 1999,45(Suppl Ⅱ ): Ⅱ 1.
5Heaton KW, O扗onnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992;102:1962-1967.
6Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
7Clouse RE, Lustman PJ, Geisman RA, Alpers DH. Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther 1994;8:409-416.
8Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Evidence-based data from animal and human experimental studies on pain relief with antidepressants:a structured review. Pain Med 2000;1:310-316.
9Drossman DA. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 1995;123:688-697.
10Nosaka K, Takenaga H, Magaribuchi T, Tamaki H. [Effects of trimebutine maleate (TM-906) on the gastrointestinal motility in anesthetized dogs. Nippon Heikatsukin Gakkai Zasshi 1984;20:407-412.
